Suprit Deshpande

Employment

• Translational Health Science and Technology Institute Scientific Project Manager
  2013 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
  PLoS pathogens 2022 DOI: 10.1371/journal.ppat.1010465
  +Save
• Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
  The Lancet. Infectious diseases 2021 DOI: 10.1016/s1473-3099(21)00680-0
  +Save
• Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities.
  Retrovirology 2021 DOI: 10.1186/s12977-021-00556-2
  +Save
• Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.
  PLoS pathogens 2021 DOI: 10.1371/journal.ppat.1008977
  +Save
• Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity
  2020 DOI: 10.1101/2020.09.09.289132
  +Save
• Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8.
  Virus research 2019 DOI: 10.1016/j.virusres.2019.197763
  +Save
• Broadly neutralizing antibodies in HIV-1 treatment and prevention.
  Therapeutic advances in vaccines and immunotherapy 2018 DOI: 10.1177/2515135518800689
  +Save
• Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category.
  Virology 2018 DOI: 10.1016/j.virol.2018.04.002
  +Save
• Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern India.
  The Journal of general virology 2018 DOI: 10.1099/jgv.0.001016
  +Save
• Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.
  The Journal of biological chemistry 2017 DOI: 10.1074/jbc.m117.803056
  +Save